Table 3.
Demographics, psychopathological symptoms, comorbidities & family history of the cohort.
| Group | Age [years] | Gender | Hallucination (any) | Acoustic | Visual | Tactile | Delusion (any) | Disorganized thinking and speech | Catatonic symptoms | Negative symptoms | Depressive symptoms | Mnestic or orientation difficulties | Comorbidity: substance dependency (previous) [%] | Comorbidity: substance dependency (previous) [%] | Positive family history for F2/F30/F31 disorder [%] | Positive family history, any psychiatric disorder [%] | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ♀ | ♂ | ||||||||||||||||
| CSF normal (n = 86) | 34 (21) [19–77] | 37 | 49 | 52.3 | 33.7 | 20.9 | 5.8 | 84.9 | 79.1 | 11.6 | 45.3 | 60.5 | 48.8 | 44.2 | 50.0 | 29.1 | 40.7 |
| CSF abnormal (n = 58) | 43 (34) [19-79] | 19 | 39 | 55.2 | 37.9 | 27.6 | 5.2 | 77.6 | 74.1 | 5.2 | 53.4 | 70.7 | 60.3 | 32.8 | 43.1 | 17.2 | 39.7 |
| p–values (CSF normal vs. abnormal) | 0.11 | 0.65 | 0.74 | 0.60 | 0.36 | 0.87 | 0.26 | 0.49 | 0.19 | 0.34 | 0.21 | 0.18 | 0.17 | 0.42 | 0.11 | 0.90 | |
| F2 (n = 84) | 33.5 (21) [19–67] | 32 | 52 | 50.0 | 36.9 | 17.9 | 6.0 | 86.9 | 78.6 | 14.3 | 47.6 | 61.9 | 47.6 | 45.2 | 50.0 | 27.4 | 36.9 |
| F1/F3-F6 (n = 22) | 42.5 (46) [20–76] | 8 | 14 | 59.1 | 27.3 | 31.8 | 0 | 63.6 | 63.6 | 4.5 | 36.4 | 68.2 | 59.1 | 36.4 | 36.4 | 18.2 | 45.5 |
| F06.2 (n = 17) | 51 (26) [22–67] | 8 | 9 | 47.1 | 23.5 | 35.3 | 11.8 | 88.2 | 88.2 | 0 | 47.1 | 58.8 | 64.7 | 23.5 | 41.2 | 23.5 | 47.1 |
|
Probable Autoimmune psychosis10 (n = 10) |
45 (33) [22–67] | 5 | 5 | 40.0 | 20.0 | 20.0 | 10.0 | 80.0 | 90.0 | 0 | 70.0 | 70.0 | 70.0 | 20.0 | 40.0 | 20.0 | 40.0 |
| Further cases (n = 7) | 52 (14) [28–62] | 3 | 5 | 57.1 | 28.6 | 57.1 | 14.3 | 100 | 85.7 | 0 | 14.3 | 42.9 | 57.1 | 28.6 | 42.9 | 28.6 | 57.1 |
| "No reliable classification" (n = 21) | 39 (30) [20–79] | 8 | 13 | 66.7 | 47.6 | 28.6 | 4.8 | 76.2 | 76.2 | 0 | 66.7 | 76.2 | 61.9 | 33.3 | 52.4 | 19.0 | 42.9 |
| p–values (F2 vs. F06.2) | 0.036 | 0.49 | 0.83 | 0.29 | 0.11 | 0.39 | 0.88 | 0.36 | 0.10 | 0.81 | 0.97 | 0.20 | 0.10 | 0.51 | 0.74 | 043 | |
Age is presented as median (interquartile range) [range (minimum–maximum value)]. Since there was no missing data for the subgroups, type of psychotic symptom and comorbidities are reported as prevalence percentage values.Age was non-Gaussian-distributed (tested by the Shapiro–Wilk test); all remaining values were tested by Pearson's chi-square. Two-sided significance values are reported.